Published
Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
No abstract availability was recorded for this entry.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
- Journal
- BMJ (Clinical research ed.)
- Date
- 2023-07-11
- Source
- PubMed
- PubMed
- 37433614
Derived topics and classifications
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.Perspectives in biology and medicine · 2023-01-01Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and clinical psychopharmacology · 2021-10-01[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept TrialClinicalTrials.gov · 2026-03-04Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress DisorderClinicalTrials.gov · 2023-06-29Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18